Lupin shares near 52-week high after drug maker receives two approvals from US regulator

Lupin shares rose on Friday after the US Meals and Drug Administration (FDA) accepted two merchandise of the Mumbai-based pharmaceutical firm. The Lupin inventory strengthened by as a lot as Rs 42.2, or 3.5 per cent, to the touch Rs 1,238.5 apiece on the upside on BSE, coming inside inches of a 52-week excessive scaled this week.   

The mixed gross sales of each merchandise within the US market are estimated at Rs 6,200 crore, based on analysts. 

Catch the most recent stock market updates right here. For all different information associated to enterprise, politics, tech, sports activities and auto, go to Zeebiz.com.